During the past decade, Hospital Angeles Mocel conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Angeles Mocel" are "Arthritis, Rheumatoid" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hospital Angeles Mocel" in a lesser frequency.

Most popular intervention types in "Hospital Angeles Mocel" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (1 trials), "Placebo tofacitinib plus Methotrexate" (1 trials), "Tasocitinib plus Methotrexate" (1 trials) and "Tofacitinib plus placebo methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Angeles Mocel" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Angeles Mocel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Angeles Mocel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Angeles Mocel, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".